benzoyl l-arginine methyl ester has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amarasekera, N; Manoharan, S; Sarker, P | 1 |
1 other study(ies) available for benzoyl l-arginine methyl ester and Cardiovascular Diseases
| Article | Year |
|---|---|
Is there a link between the prevalence of cardiovascular disease, diabetes, kidney disease, chronic obstructive pulmonary disease and malignancies and the severity of COVID-19 within the BAME population?
Topics: Arginine; Cardiovascular Diseases; Comorbidity; COVID-19; Diabetes Mellitus; Humans; Kidney Diseases; Neoplasms; Prevalence; Pulmonary Disease, Chronic Obstructive; Risk Factors; SARS-CoV-2 | 2021 |